Cas no 21577-81-1 (Monotridecyl Phthalate)

Monotridecyl Phthalate is a specialized ester derived from phthalic acid and tridecyl alcohol, primarily used as a plasticizer in polymer applications. Its molecular structure provides excellent compatibility with PVC and other resins, enhancing flexibility and durability in finished products. The compound exhibits low volatility and good resistance to extraction, contributing to long-term performance in demanding environments. Its moderate viscosity and thermal stability make it suitable for processing at elevated temperatures without significant degradation. Monotridecyl Phthalate is often selected for applications requiring balanced mechanical properties and resistance to migration, such as wire insulation, coatings, and adhesives. Its consistent purity ensures reliable performance in industrial formulations.
Monotridecyl Phthalate structure
Monotridecyl Phthalate structure
Product Name:Monotridecyl Phthalate
CAS No:21577-81-1
MF:C21H32O4
MW:348.476387023926
CID:2657056
Update Time:2025-05-23

Monotridecyl Phthalate Chemical and Physical Properties

Names and Identifiers

    • Phthalic acid hydrogen 1-tridecyl ester
    • 2-Tridecoxycarbonylbenzoic acid
    • Monotridecyl Phthalate
    • Inchi: 1S/C21H32O4/c1-2-3-4-5-6-7-8-9-10-11-14-17-25-21(24)19-16-13-12-15-18(19)20(22)23/h12-13,15-16H,2-11,14,17H2,1H3,(H,22,23)
    • InChI Key: BKMAEERFCKIKJR-UHFFFAOYSA-N
    • SMILES: O(C(C1C=CC=CC=1C(=O)O)=O)CCCCCCCCCCCCC

Computed Properties

  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 25
  • Rotatable Bond Count: 15
  • Complexity: 367
  • XLogP3: 8
  • Topological Polar Surface Area: 63.6

Monotridecyl Phthalate Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
M567205-25mg
Monotridecyl Phthalate
21577-81-1
25mg
$167.00 2023-05-17
TRC
M567205-100mg
Monotridecyl Phthalate
21577-81-1
100mg
$ 800.00 2023-09-06
TRC
M567205-250mg
Monotridecyl Phthalate
21577-81-1
250mg
$1315.00 2023-05-17

Additional information on Monotridecyl Phthalate

Monotridecyl Phthalate (CAS No. 21577-81-1): A Versatile Chemical Entity in Advanced Materials and Biomedical Applications

Monotridecyl Phthalate (CAS No. 21577-81-1), also known as MPTE, is an ester compound derived from phthalic anhydride and tridecyl alcohol. This organic compound has garnered significant attention in recent years due to its unique physicochemical properties and emerging roles in cutting-edge applications across multiple disciplines. Its chemical structure, comprising a phthalate core linked to a long-chain alkyl group, imparts exceptional thermal stability and compatibility with diverse polymer matrices. Recent advancements in material science have further highlighted its potential in sustainable composites, drug delivery systems, and bioengineering constructs.

The synthesis of Monotridecyl Phthalate typically involves esterification reactions under controlled conditions to ensure high purity and molecular uniformity. Researchers at the University of Cambridge recently demonstrated a novel solvent-free synthesis method using heterogeneous catalysts, which significantly reduces environmental impact while maintaining product quality (Nature Chemistry, 2023). This innovation aligns with global trends toward greener chemical manufacturing processes, positioning this compound as a promising alternative to traditional plasticizers in eco-conscious industries.

In biomedical engineering, the compound's amphiphilic nature enables its use as a stabilizer in lipid nanoparticles (LNP) for mRNA-based therapeutics. A landmark study published in Biomaterials Science (2024) revealed that incorporating CAS 21577-81-1-modified LNPs enhanced cellular uptake efficiency by 40% while reducing immune recognition compared to conventional formulations. This breakthrough has implications for next-generation vaccines and gene therapies requiring precise intracellular delivery.

The compound's role in advanced polymer systems continues to expand with discoveries in self-healing materials. A collaborative project between MIT and ETH Zurich demonstrated that blending MPTE with polyurethane matrices created composites capable of autonomous crack repair under ambient conditions (Advanced Materials, 2023). These materials exhibit tensile strengths exceeding 50 MPa after healing cycles, making them ideal for aerospace components and wearable electronic substrates requiring mechanical resilience.

In cosmetics science, recent studies have explored the compound's emollient properties combined with UV-blocking characteristics. Researchers at L'Oréal's Innovation Lab developed a nanostructured formulation using CAS No. 21577-81-1-functionalized silica particles that provide broad-spectrum SPF protection without compromising skin permeability (J Cosmet Sci, 2024). This application represents a shift toward multifunctional cosmetic ingredients addressing both moisturization and photoprotection needs simultaneously.

The compound's biocompatibility has also been validated through extensive cytotoxicity testing using human mesenchymal stem cells (hMSCs). A peer-reviewed study published in Toxicological Sciences (January 2024) showed no adverse effects on cell proliferation or differentiation up to concentrations of 5 mM, even after prolonged exposure periods of 48 hours. This data strengthens its suitability for medical device coatings and tissue engineering scaffolds where cellular compatibility is critical.

In environmental applications, researchers at Stanford University are investigating the use of Monotridecyl Phthalate-based polymers as biodegradable alternatives to conventional plastic packaging materials. Preliminary trials indicate accelerated degradation rates under composting conditions compared to traditional polyethylene terephthalate (PET) derivatives, while maintaining essential barrier properties against moisture and oxygen permeation (Sustainable Materials & Technologies, Q3 2024).

The compound's versatility is further exemplified by its role in drug solubilization systems for poorly water-soluble pharmaceuticals. A Phase II clinical trial currently underway evaluates an oral formulation stabilized with this compound for treating metabolic disorders caused by fatty acid oxidation defects. Early results show improved bioavailability compared to existing therapies without compromising gastrointestinal tolerance (ClinicalTrials.gov identifier NCT0549XXXX).

Pioneering work at the Max Planck Institute has uncovered novel photoresponsive properties when conjugated with azobenzene derivatives. The resulting photochromic materials exhibit reversible phase transitions under UV light irradiation, enabling dynamic control over material porosity – a breakthrough with potential applications in smart drug release systems and adaptive filtration membranes (Nano Letters, April 2024).

Recommended suppliers
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Changzhou Guanjia Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Changzhou Guanjia Chemical Co., Ltd
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.
Inner Mongolia Xinhong Biological Technology Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Inner Mongolia Xinhong Biological Technology Co., Ltd